{"id":"NCT00423657","sponsor":"Forest Laboratories","briefTitle":"Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections","officialTitle":"A Phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin and Skin Structure Infection (cSSSI)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-03","primaryCompletion":"2007-12","completion":"2007-12","firstPosted":"2007-01-18","resultsPosted":"2010-11-18","lastUpdate":"2017-03-14"},"enrollment":680,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Bacterial Infections"],"interventions":[{"type":"DRUG","name":"ceftaroline","otherNames":["Experimental"]},{"type":"DRUG","name":"vancomycin plus aztreonam","otherNames":["Active Comparator"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Ceftaroline fosamil for Injection","type":"EXPERIMENTAL"},{"label":"IV Vancomycin plus IV Aztreonam","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of complicated skin infections in adults.","primaryOutcome":{"measure":"Clinical Cure Rate at Test of Cure (TOC) (MITT Population)","timeFrame":"8-15 days after last dose of study drug administration","effectByArm":[{"arm":"Ceftaroline for Injection","deltaMin":291,"sd":null},{"arm":"IV Vancomycin Plus IV Aztreonam","deltaMin":289,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":2},"locations":{"siteCount":54,"countries":["United States","Argentina","Austria","Brazil","Chile","Germany","Latvia","Mexico","Poland","Russia","Ukraine","United Kingdom"]},"refs":{"pmids":["34922058","34741280","30716446","30597021","21115456","21115455","20695801"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":14,"n":341},"commonTop":["Pruritus","Nausea","Diarrhea","Headache","Rash"]}}